ACM
RVNC
AlphaCrest Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-17,642
| Closed | -$476K | – | 1202 |
|
|
2022
Q3 | $476K | Sell |
17,642
-5,398
| -23% | -$146K | 0.03% | 994 |
|
|
2022
Q2 | $318K | Buy |
+23,040
| New | +$318K | 0.02% | 1102 |
|
|
2022
Q1 | – | Sell |
-34,910
| Closed | -$570K | – | 1438 |
|
|
2021
Q4 | $570K | Buy |
+34,910
| New | +$570K | 0.02% | 1054 |
|
|
2021
Q3 | – | Sell |
-17,700
| Closed | -$525K | – | 1406 |
|
|
2021
Q2 | $525K | Hold |
17,700
| – | – | 0.02% | 942 |
|
|
2021
Q1 | $495K | Sell |
17,700
-6,300
| -26% | -$176K | 0.03% | 798 |
|
|
2020
Q4 | $680K | Buy |
24,000
+12,900
| +116% | +$366K | 0.06% | 484 |
|
|
2020
Q3 | $279K | Buy |
+11,100
| New | +$279K | 0.03% | 898 |
|
|
2019
Q3 | – | Sell |
-17,600
| Closed | -$228K | – | 1354 |
|
|
2019
Q2 | $228K | Buy |
17,600
+5,700
| +48% | +$73.8K | 0.02% | 941 |
|
|
2019
Q1 | $188K | Buy |
+11,900
| New | +$188K | 0.03% | 784 |
|